191 related articles for article (PubMed ID: 27981451)
1. Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).
Oliveira CP; Prado WA; Lavayen V; Büttenbender SL; Beckenkamp A; Martins BS; Lüdtke DS; Campo LF; Rodembusch FS; Buffon A; Pessoa A; Guterres SS; Pohlmann AR
Pharm Res; 2017 Feb; 34(2):438-452. PubMed ID: 27981451
[TBL] [Abstract][Full Text] [Related]
2. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity.
de Cristo Soares Alves A; Lavayen V; Figueiró F; Dallemole DR; de Fraga Dias A; Cé R; Battastini AMO; Guterres SS; Pohlmann AR
Pharm Res; 2020 May; 37(6):91. PubMed ID: 32385723
[TBL] [Abstract][Full Text] [Related]
4. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
Safwat S; Hathout RM; Ishak RA; Mortada ND
J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
[TBL] [Abstract][Full Text] [Related]
5. Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type I.
Mayer FQ; Adorne MD; Bender EA; de Carvalho TG; Dilda AC; Beck RC; Guterres SS; Giugliani R; Matte U; Pohlmann AR
Pharm Res; 2015 Mar; 32(3):941-54. PubMed ID: 25208876
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression.
de Castro Leão M; Raffin Pohlmann A; de Cristo Soares Alves A; Helena Poliselli Farsky S; Klimuk Uchiyama M; Araki K; Sandri S; Stanisçuaski Guterres S; Alves Castro I
Eur J Pharm Biopharm; 2021 Feb; 159():99-107. PubMed ID: 33358940
[TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
Ding B; Chen P; Kong Y; Zhai Y; Pang X; Dou J; Zhai G
J Drug Target; 2014 Jan; 22(1):67-75. PubMed ID: 24099639
[TBL] [Abstract][Full Text] [Related]
9. Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.
Cé R; Lavayen V; Couto GK; De Marchi JGB; Pacheco BZ; Natividade LA; Fracari TO; Ciocheta TM; de Cristo Soares Alves A; Jornada DS; Guterres SS; Seixas F; Collares T; Pohlmann AR
Pharm Res; 2021 Feb; 38(2):301-317. PubMed ID: 33608808
[TBL] [Abstract][Full Text] [Related]
10. Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules.
Michalowski CB; Arbo MD; Altknecht L; Anciuti AN; Abreu ASG; Alencar LMR; Pohlmann AR; Garcia SC; Guterres SS
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963659
[TBL] [Abstract][Full Text] [Related]
11. Characterization of different functionalized lipidic nanocapsules as potential drug carriers.
Sánchez-Moreno P; Ortega-Vinuesa JL; Martín-Rodríguez A; Boulaiz H; Marchal-Corrales JA; Peula-García JM
Int J Mol Sci; 2012; 13(2):2405-2424. PubMed ID: 22408461
[TBL] [Abstract][Full Text] [Related]
12. Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration.
Paese K; Ortiz M; Frank LA; Külkamp-Guerreiro IC; Rolim CM; Barros DM; Pohlmann AR; Guterres SS
AAPS PharmSciTech; 2017 Jan; 18(1):212-223. PubMed ID: 26956145
[TBL] [Abstract][Full Text] [Related]
13. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells.
Niazvand F; Orazizadeh M; Khorsandi L; Abbaspour M; Mansouri E; Khodadadi A
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013662
[No Abstract] [Full Text] [Related]
14. Cytokinetic study of MCF-7 cells treated with commercial and recombinant bromelain.
Fouz N; Amid A; Hashim YZ
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6709-14. PubMed ID: 24377593
[TBL] [Abstract][Full Text] [Related]
15. Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: Cytotoxicity in human breast cancer cell line and in vitro uptake mechanism.
Antonow MB; Asbahr ACC; Raddatz P; Beckenkamp A; Buffon A; Guterres SS; Pohlmann AR
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():374-382. PubMed ID: 28482541
[TBL] [Abstract][Full Text] [Related]
16. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis.
Broering MF; Leão MC; da Rocha GHO; Scharf P; Xavier LF; Alves ACS; Castro I; Reutelingsperger C; Uchiyama MK; Araki K; Guterres SS; Pohlmann AR; Farsky SHP
Eur J Pharm Biopharm; 2022 Dec; 181():49-59. PubMed ID: 36334840
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of poly-ɛ-caprolactone lipid-core nanocapsules loaded with lycopene-rich extract from red guava (Psidium guajava L.) on breast cancer cells.
Vasconcelos AG; Valim MO; Amorim AGN; do Amaral CP; de Almeida MP; Borges TKS; Socodato R; Portugal CC; Brand GD; Mattos JSC; Relvas J; Plácido A; Eaton P; Ramos DAR; Kückelhaus SAS; Leite JRSA
Food Res Int; 2020 Oct; 136():109548. PubMed ID: 32846600
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.
Fontana MC; Beckenkamp A; Buffon A; Beck RC
Int J Nanomedicine; 2014; 9():2979-91. PubMed ID: 24971009
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
20. In vitro performance of free and encapsulated bromelain.
Ataide JA; Cefali LC; Figueiredo MC; Braga LEO; Ruiz ALTG; Foglio MA; Oliveira-Nascimento L; Mazzola PG
Sci Rep; 2021 May; 11(1):10195. PubMed ID: 33986357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
